Skip to main content
AmigoFish

🧬 Science Is Twenty Percent of the Problem | James Evans Rerelease (2/3)

From The Biotech Startups Podcast Β· Β· 21 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Need new or refurbished lab equipment? Excedr provides research labs with equipment leases on founder-friendly terms to support paths to exceptional outcomes. Learn more at https://www.excedr.com/ and explore our partner network: https://www.excedr.com/partners

β€œThe science does need to be good, but it's probably 10 or 20% of the problem.”

Paul Matsudaira took a job in Singapore, and James Evans did not wake up one morning craving entrepreneurship. He left MIT's Whitehead Institute, bounced through venture-backed biotechs, and got a baptism of fire defending data in rooms that wanted a fight. One San Diego client won a contract, and that was enough to plant PhenoVista in California with a year of runway and no paying customers yet.

The culture shock was the point. Academia does not restructure a lab because a fund's priorities changed. Private-sector science does, and it felt unfair. His wife is the reason the company exists. She believed first, then kept bringing home the HR and ops problems nobody warns you about. If people had told him, he says he wouldn't have listened.

iPS-derived cells were still new, the market had a hole, and they never wrote a business plan. They mapped rent, salaries, and grants on the back of the old-fashioned way, because James had no fundraising network from those earlier VC-backed seats. Bootstrap was necessity, not branding. Getting Erica on payroll was the moment the tissue-culture-in-a-hot-room era had to get slightly more professional.

Key Topics Covered:

- Leaving MIT when Paul Matsudaira moved to Singapore

- The baptism of fire inside venture-backed biotech

- Moving the company to San Diego on a client contract

- A year of runway and zero paying clients

- Why academic culture and VC-backed science collide

- Starting PhenoVista because his wife believed first

- Science as 10 to 20 percent of the actual problem

- iPS cells, no business plan, and bootstrap by necessity

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

──────────────────────────────────────────────────

Links:

Subscribe to the Podcast:

Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994

Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4

YouTube: https://www.youtube.com/@thebiotechstartupspodcast

Website: https://www.thebiotechstartupspodcast.com/?utm_source=podcast&utm_medium=show-notes&utm_campaign=the-biotech-startups-podcast-ep292

Find our guest, James Evans, at these links:

LinkedIn: https://www.linkedin.com/in/jamesgevans

Website: https://phenovista.com/

Find our host, Jon Chee, at these links:

LinkedIn: https://www.linkedin.com/in/jonchee/

Learn more about Excedr:

LinkedIn: https://www.linkedin.com/company/excedr/

Website: https://www.excedr.com/

Intro & Outro Songs Created by OkKyojin:

https://flow.page/kyojin

Resources & Articles:

How to Choose the Right Contract Research Organization: https://www.excedr.com/blog/contract-research-organizations

A Guide to Writing a Small Business Grant Proposal: https://www.excedr.com/blog/how-to-write-a-small-business-grant-proposal

How Do Core Labs Support Life Science Research?: https://www.excedr.com/blog/core-labs

Companies, Universities, & People Mentioned:

Whitehead Institute: https://wi.mit.edu/

Massachusetts Institute of Technology: https://www.mit.edu/

National University of Singapore: https://www.nus.edu.sg/

Timestamps:

00:00 Intro

01:19 Paul Moves to Singapore

04:06 Baptism of Fire

04:16 A Client in San Diego

05:27 No Paying Clients and a Year of Runway

07:26 Getting Erica

09:06 Academia Meets Venture Backing

09:31 Restructuring That Felt Unfair

12:42 I Wouldn't Have Started Without My Wife

14:05 You Wouldn't Listen If They Told You

14:15 Science Is Twenty Percent of the Problem

15:45 iPS Cells and a Gap in the Market

17:17 We Never Wrote a Business Plan

18:32 Bootstrap by Necessity…

Back to The Biotech Startups Podcast Β· Report a problem